New footrot vaccine
A second drug company has announced the release of a vaccine to combat footrot. Cooper, McDougall, and Robertson, Ltd, said this week that the new vaccine would be commercially produced in New Zealand, and would soon be available to farmers.
The development of the vaccine stems from research on footrot at the McMaster Laboratory, Sydney, by the Commonwealth Scientific and Industrial Research Organisation. The announcement by Cooper, McDougall and Robertson said the commercial feasibility of its vaccine had been proved at the
Wellcome Foundation’s laboratories in England. The vaccine was released there for commercial use last month. Estimates of the benefits of the vaccine include a saving of sl6m in Australia and about sBm in New Zealand. It is certainly one of the most welcome stock health developments of recent times.
Permanent link to this item
https://paperspast.natlib.govt.nz/newspapers/CHP19710910.2.131
Bibliographic details
Press, Volume CXI, Issue 32708, 10 September 1971, Page 15
Word Count
134New footrot vaccine Press, Volume CXI, Issue 32708, 10 September 1971, Page 15
Using This Item
Stuff Ltd is the copyright owner for the Press. You can reproduce in-copyright material from this newspaper for non-commercial use under a Creative Commons BY-NC-SA 3.0 New Zealand licence. This newspaper is not available for commercial use without the consent of Stuff Ltd. For advice on reproduction of out-of-copyright material from this newspaper, please refer to the Copyright guide.
Acknowledgements
This newspaper was digitised in partnership with Christchurch City Libraries.
Log in